Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
Erlotinib Versus Carboplatin/Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
An Open-label, Phase I Trial of Intravenous ASA404 Administered in Combination With Paclitaxel and Carboplatin in Japanese Patients With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Angiogenesis With Positron Emission Tomography (PET) Tracer Uptake
- Status
- COMPLETED
- Phase
- N/A
NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 1b Study With Volociximab in Combination With Carboplatin, Paclitaxel, and Bevacizumab in First-line, Advanced Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy of Erlotinib for Brain Metastasis of Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Avastin (Bevacizumab) in Combination With Docetaxel and Cisplatin in Patients With Metastatic or Locally Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lower Dose Chemotherapy Given More Frequent With Avastin to Treat Advanced Non-Squamous Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Allogeneic Cellular Vaccine 1650-G for Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate KOS-1584 in Patients With Advanced or Metastatic Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Sorafenib + Carboplatin and Docetaxel in First Line Treatment of Stage IIIB/IV NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Carboplatin, Abraxane, and Bevacizumab in Previously Untreated Patients With Advanced Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Feasibility of Exercise With Post-Op Lung Cancer Patients
- Status
- COMPLETED
- Phase
- NA
Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2